Literature DB >> 1917227

Influence of anabolic steroids on body composition, blood pressure, lipid profile and liver functions in body builders.

H Kuipers1, J A Wijnen, F Hartgens, S M Willems.   

Abstract

The effects of anabolic steroids on body composition, blood pressure, lipid profile and liver functions were studied in male body builders who received a weekly i.m. injection of nandrolone-decanoate (100 mg) or placebo for 8 weeks in a double blind way. In addition, 5 body builders received the same dosage of nandrolone-decanoate or placebo, in a double blind cross-over design during two 8-week periods, interspersed by 12 weeks. Anabolic steroids induced a 25-27% decrease in HDL-cholesterol, which was virtually reversed 6 weeks after cessation of drug use. In the SAD group an increase in diastolic blood pressure was observed, which returned to pre-anabolic values approximately 6 weeks after cessation of drug administration. No deleterious effects of anabolic drugs on plasma activity of liver enzymes were found. Increases in lean body mass were found in all groups, though the increase in the subjects who received anabolic steroids was superior to that in the placebo-treated subjects. The increase in lean body mass suggests increases in muscle mass.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1917227     DOI: 10.1055/s-2007-1024704

Source DB:  PubMed          Journal:  Int J Sports Med        ISSN: 0172-4622            Impact factor:   3.118


  23 in total

1.  Gym and tonic: a profile of 100 male steroid users.

Authors:  N A Evans
Journal:  Br J Sports Med       Date:  1997-03       Impact factor: 13.800

Review 2.  Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern?

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Drug Alcohol Depend       Date:  2008-07-02       Impact factor: 4.492

Review 3.  Cardiac and metabolic effects of anabolic-androgenic steroid abuse on lipids, blood pressure, left ventricular dimensions, and rhythm.

Authors:  Suraj Achar; Armand Rostamian; Sanjiv M Narayan
Journal:  Am J Cardiol       Date:  2010-09-15       Impact factor: 2.778

4.  Licit steroid use--hope for the future.

Authors:  A P Millar
Journal:  Br J Sports Med       Date:  1994-06       Impact factor: 13.800

Review 5.  Medical issues associated with anabolic steroid use: are they exaggerated?

Authors:  Jay R Hoffman; Nicholas A Ratamess
Journal:  J Sports Sci Med       Date:  2006-06-01       Impact factor: 2.988

Review 6.  Effects of androgenic-anabolic steroids in athletes.

Authors:  Fred Hartgens; Harm Kuipers
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

7.  Mechanism of action of bolandiol (19-nortestosterone-3beta,17beta-diol), a unique anabolic steroid with androgenic, estrogenic, and progestational activities.

Authors:  Barbara J Attardi; Stephanie T Page; Sheri A Hild; Christopher C Coss; Alvin M Matsumoto
Journal:  J Steroid Biochem Mol Biol       Date:  2009-11-24       Impact factor: 4.292

8.  Diverse effects of stanozolol in C57BL/6J and A/J mouse strains.

Authors:  Arimantas Lionikas; David A Blizard
Journal:  Eur J Appl Physiol       Date:  2008-03-19       Impact factor: 3.078

9.  Tissue selectivity of the anabolic steroid, 19-nor-4-androstenediol-3beta,17beta-diol in male Sprague Dawley rats: selective stimulation of muscle mass and bone mineral density relative to prostate mass.

Authors:  Stephanie T Page; Brett T Marck; James M Tolliver; Alvin M Matsumoto
Journal:  Endocrinology       Date:  2007-12-20       Impact factor: 4.736

Review 10.  Anabolic steroid use: patterns of use and detection of doping.

Authors:  Michael R Graham; Bruce Davies; Fergal M Grace; Andrew Kicman; Julien S Baker
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.